Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observational Vax-On-Third study

F. Nelli,D. Giannarelli, A. Fabbri, M. A. Silvestri,J. R. Giron Berrios, A. Virtuoso, E. Marrucci, M. Schirripa, M. Mazzotta, A. Onorato, V. Panichi, G. Topini,G. Pessina, F. Natoni, C. Signorelli, M. G. Chilelli,F. Primi, E. M. Ruggeri

Annals of Oncology(2022)

引用 6|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要